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linical evidence
Atrial ﬁbrillation (AF) has a rich history. Probably the earli-
st description of chaotic irregularity of the pulse is Chinese, in
he Yellow Emperors Classic of Internal Medicine. In recorded
istory, William Harvey reported “auricular ﬁbrillation” of ani-
als in 1628. Owing to the invention of the electrocardiogram
y Willem Einthoven in 1903, Sir Thomas Lewis recorded clear f
aves of AF and established it as a clinical entity. During the past
00 years, there has been an explosion of research into various
elds of the mechanisms (ectopic focus vs. re-entry) and treat-
ents (rhythm vs. rate control, antiarrhythmic agents vs. catheter
blation, antiplatelet vs. anticoagulation). Now, the focus of treat-
ents of AF is shifting to improve quality of life and prognosis of
F patients. After 50 years’ monopoly of a vitamin K antagonist,
arfarin, novel oral anticoagulants are on the market now. For the
valuation of these new drugs, we need basic information on the
revalence and incidence of AF.
Prevalence and incidence of AF vary among different ethnic
roups, socio-economic statuses, genders, ages, underlying heart
iseases, and many other factors. Although the prevalence of AF
n Japan is well known to be lower than in the USA and Europe,
t has been increasing with the progress in aging of our society.
he management of AF is problematic due to the lack of proper
ssessment of drugs and tools based on epidemiological surveys.
or appropriate management of patients with AF, we need ideally
ational survey systems on prevalence and incidence of cardiovas-
ular diseases or the accumulation of knowledge on population-
nd clinical-based studies at the very least. In this editorial, mainly
he etiological studies from Japan will be introduced.
opulation- or community-based studies
In population-based studies, the prevalence and incidence of AF
loser reﬂect the characteristics of the general population in Japan
Table 1). The incidence of AF was reported from an early cohort
f the Hisayama study between 1961 and 1983 [1].  The overall
ncidence was 4 per 1000 person-years in men, 2 in women. The
DOI of original article: http://dx.doi.org/10.1016/j.jjcc.2012.12.002.
914-5087/$ – see front matter © 2013 Published by Elsevier Ltd on behalf of Japanese Co
ttp://dx.doi.org/10.1016/j.jjcc.2013.02.005incidence of AF increased with age in both men  and women  [1].
Kitamura et al. conducted the cohort study of 6057 residents in a
rural area of Akita from 1963 to 1987 and reported an incidence
of 1.4% overall, 2.1% in men, and 0.8% in women [2].  The Radia-
tion Effects Research Foundation conducted a longitudinal cohort
study from 1968 to1986, in which a total of 6990 subjects were fol-
lowed biannually [3].  The incidence of AF was about 0.2% in those
aged in their 40s and early 50s, and increased to 0.6% in the late
50s, and then increased almost linearly up to 2.5% in the end of
the 80s. In the National Survey on Cardiovascular Diseases in 1980,
1990, and 2000, the prevalence increased along with age and was
greater in men  than in women, but no signiﬁcant increase in the
age-adjusted prevalence of AF was observed during 1980–2000 [4].
In an observational cohort study based on an annual health check-
up program for 28,449 participants aged 20 years or older in Niigata
from 1996 to 2005, the incidence of AF per 1000 person-years was
4.1 in men  and 1.3 in women [5].  In 2003, a large population-based
study conducted with the support of the Japanese Society of Cir-
culation included 630,138 participants aged 40 years or older [6].
These data were obtained from periodic health check-ups of com-
munity residents, employees, and local governments all over Japan
in 2003. The prevalence of AF in the elderly participants was higher
than that in younger adults (4.4% for men  and 2.2% for women aged
80 years or older vs. 0.8% and 0.1% for those aged in their 50s). The
prevalence of AF was  consistently higher in men than in women
among all age groups, with an overall rate of 1.35% in men  and
0.43% in women. Based on the Japanese Registry of Residents in
2005 by the Ministry of Internal Affairs and Communications Japan,
the overall prevalence of AF in Japan was estimated to be 0.56%
in 2005 [6].  In Kurashiki-city, a community-based study was  also
conducted in 2006 and included a total of 41,436 residents aged 40
years or older, the observed rate of AF was  0.5% in men and 0.2%
in women aged 40–59 years, 2.3% in men  and 1.0% in women aged
60–79 years, and 3.5% in men  and 2.5% in women over 80 years,
and the overall prevalence was  1.6% [7].  Follow-up of this study
was conducted until 2007 with 30,010 participants aged 40 years
or older [8].  As the result, the incidence of AF per 1000 person-years
was 9.3 overall.
Hospital-based epidemiological studies
Several hospital-based surveillance studies on AF also reported
different prevalences according to the characteristics of participat-
ing hospitals or clinics, their locality, age structure of the subjects,
and other factors (Table 2). Most of the previous reports were
from emergency hospitals, specialized cardiovascular hospitals,
llege of Cardiology.
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Table  1
Population-based studies.
[References]
Hisayama
study [1]
Akita study
[2]
Nagasaki
study [3]
National
Survey on
Cardiovasc.
Dis. [4]
Niigata
study [5]
Jap. Soc.
Circulation
[6]
Kurashiki
study (1)
[7]
Kurashiki
study (2)
[8]
Study period 1961–1983 1963–1987 1968–1986 1980, 1990, 2000 1996–2005 2003 2006 2006–2007
Publication year 1998 1991 1989 2005 2008 2009 2008 2010
No.  of subjects 1610 6057 6990 23,713 28,449 630,138 41,436 30,010
M/W  – – – 10,042/13,671 9805/18,644 295,252/334,886 13,963/27,473 9874/20,136
Prevalence of AF
Overall (%) – 1.4
40s–50s: 0.2% 50s: 0.6, 0.4, 0.6
–
50s: 0.4 40–59: 0.2
–60s:  0.5% >70s: 3.1, 2.9, 2.7 70s: 2.1 60–79:1.5
80s: 2.5% >80: 3.2 >80: 2.8
All: 1.6
Men  (%) – 2.1 – 50s: 0.8, 0.8, 0.4 – 50s: 0.78 40–59: 0.5 –
>70s: 3.7, 4.3, 3.5 70s: 3.44 60–79: 2.3
>80: 4.4 >80: 3.5
All: 2.4
Women  (%) – 0.8 –
50s: 0.5, 0.1, 0.7
–
50s: 0.12 40–59: 0.2
–>70s: 2.6, 1.9, 2.1 70s: 1.12 60–79: 1.0
>80: 2.2 >80: 2.5
All: 1.2
Incidence of AF
Overall/1000
person-years
– – – – – – – 9.3
Men/1000 4  – – – 4.1 – – –
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Women/1000
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2  – – – 
nd general hospitals. Atarashi et al. reported the prevalence of
F at a general hospital in an urban area as being 2.5% from
079 consecutive patients in 1983. The prevalence of AF was  higher
n men  than in women (2.7% and 2.3%, respectively) [9].  In a com-
unity clinic of rural area of northern Kyoto where the aging
f the population has been advancing, the prevalence of AF was
.0% [10]. On the other hand, the prevalence rates reported from
pecialized cardiovascular hospitals were higher than that of the
ormer general hospital and local community clinics (13.4% from
he Hokkaido Atrial Fibrillation Study Group and 11.8% from the
hinken Database 2004) [11,12].
linical multicenter study on AF
The J-RHYTHM Registry is conducted as a multicenter prospec-
ive study on the present status of AF and optimal anticoagulation
reatment [13]. The 158 participating institutions consisted of
ainly university hospitals and speciﬁc cardiovascular centers.
egistration was conducted from 2007 to 2009, and 7937 patients
able 2
ospital-based epidemiological studies.
General hospital Community c
[References] Atarashi et al. [9] Imanaka [10]
Study period 1983 2007–2007 
Publication year 1986 2008 
No.  of subjects 5079 550 
M/W  2546/2533 – 
Prevalence of AF
Overall (%) 2.5 8.0 
Men  (%) 2.7 2.9 
Women  (%) 2.3 5.1 
Incidence of AF
Overall/1000 person-years – 3.8 
Men/1000 person-years – – 
Women/1000 person-years – – 1.3 – – –
with AF (5468 men  and 2469 women) were registered. Of them,
34.2% were over the age of 75 years. Overall, 87.3% of patients were
taking warfarin and the underlying cardiovascular diseases were
mainly hypertension (59.1% of the patients).
In the present issue of the Journal, Akao et al. present their
results of the Fushimi registry that was carried out by the med-
ical institutions in the southern end of the city of Kyoto [14]. A
total of 76 institutions including not only specialized cardiovascular
institutions but also private clinics took part in the survey research
project. Private clinics are deﬁnitely at the ﬁrst line of diagnosis of
AF because the vast majority of patients visit them as their fam-
ily doctors. It is worthwhile to have private clinicians take part in
this kind of project not only because the data collected by them
will most likely reﬂect the real prevalence of AF in Japan but also
because private practitioners will play more important roles in the
coming years that we expect more AF patients to be treated.
This study showed accumulated clinical aspects of AF patients in
the particular district. Some of their results were compatible with
what the previous studies revealed, and others were different as the
linic Cardiovascular hospitals
 Hokkaido study [11] Shinken database 2004 [12]
1995 2004
2000 2008
19,825 2412
1659/1008 –
13.4 11.8
8.4 –
5.1 –
– –
– –
– –
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uthors stated that the Fushimi AF patients were older, had higher
isk proﬁles with more co-morbidities, but received warfarin pre-
criptions at a lower rate than those in the J-RHYTHM registry study.
hose differences are important to know in daily practice since the
o-called “standard care or treatment” should be adjusted or mod-
ﬁed according to the individual patient who receives the beneﬁt.
The Fushimi AF Registry provided a unique snapshot of cur-
ent AF management in an urban community in Japan. What the
uthors elucidated would apply to many clinical scenes at daily
ractices in Japan. However, the uniqueness suggests to us a pic-
ure of where we  stand in the management of AF and also indicates
he challenging problems to be solved in the coming years.
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